The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 1985;8(2): 89-193.
Copper transport: an overview. Proc Soc Exp Biol Med 1991 Feb;196(2):130-140.
A delicate balance: homeostatic control of copper uptake and distribution. J Nutr 1999 Jul;129(7):1251-1260.
Copper and iron disorders of the brain. Annu Rev Neurosci 2007;30:317-337.
Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders. Neuropathol Appl Neurobiol 2007 Apr;33(2):212-225.
Metabolic and molecular bases of Menkes disease and occipital horn syndrome. Pediatr Dev Pathol 1998 Jan-Feb;1(1):85-98.
Fulminant hepatic failure: a fatal presentation of Wilson disease. J Postgrad Med Educ Res 2016;50(1):261-267.
Metals in motor neuron diseases. Exp Biol Med (Maywood) 2006 Oct;231(9):1481-1487.
Function and regulation of human copper-transporting ATPases. Physiol Rev 2007 Jul;87(3):1011-1046.
Toxic proteins in neurodegenerative disease. Science 2002 Jun 14;296(5575):1991-1995.
Mechanisms of copper ion mediated Huntington's disease progression. PLoS One 2007 Mar 28;2(3):e334
The synucleins are a family of redox-active copper binding proteins. Biochemistry 2011 Jan 11;50(1):37-47.
Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alphasynuclein. Inorg Chem 2010 Nov 15;49(2):10668-10679.
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 2013 Apr;73(4):554-559.
